Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
4-Dimethylamino Benzoic Acid-d6
CAS:Formula:C9H5D6NO2Color and Shape:White To Off-White SolidMolecular weight:171.23Gadoxetate Disodium Salt (Mixture of Diastereomers)
CAS:Formula:C23H28GdN3O11·2NaColor and Shape:White To Off-White SolidMolecular weight:679.74 2*22.99Spectinomycin dihydrochloride pentahydrate
CAS:Controlled ProductFormula:C14H24N2O7ClHH2OColor and Shape:NeatMolecular weight:495.3478L-Tyrosine Ethyl Ester Hydrochloride
CAS:Formula:C11H15NO3·HClPurity:>98.0%(T)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:245.70N-Nitrosodiethylamine
CAS:Controlled ProductApplications N-Nitrosodiethylamine (DEN) is a widely occurring nitrosamine that is one of the most important environmental carcinogens (1) primarily inducing tumors of liver (2,3). Drinking water contaminant candidate list 3 (CCL 3) compound as per United States Environmental Protection Agency (EPA), environmental, and food contaminants.NDMA and NDEA were found as an impurity in generic versions of valsartan, losartan and irbesartan. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References 1. Farber, E. et al.: Cancer Res. 1984 Oct;44(10):4217-23.2. el-Demerdash, E. et al.: Anticancer Res. 2002 Mar-Apr;22(2A):977-84.3. Kweon, S. et al.: Life Sci. 2003 Sep 26;73(19):2515-26.Formula:C4H10N2OColor and Shape:YellowMolecular weight:102.14Valganciclovir-d5 DiHCl (Mixture of Diastereomers)
CAS:Formula:C14H17D5N6O5·2HClMolecular weight:359.40 2*36.46
